The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Tissue engineered scaffolding allows reproduction of cartilage tissue

Suwon, Korea May 09, 2007 - A new study examines the use of tissue-engineered scaffolding made of cartilage cells, which have a limited ability to heal naturally, to replace defective cartilage tissue. Cartilage cells are extracted and seeded to the scaffold which is implanted into the body, where new cartilage tissue is grown along the structure. The study appears in the journal Artificial Organs.

The procedure was extremely successful in tested mice as the study found these scaffolds to be a far more effective means of regenerating cartilage than traditional therapy. The shrinkage of cartilage that occurs frequently in other tissue engineering methods, and often renders the replacement tissue wrongly-sized for implantation, did not occur in the study. The scaffolding allowed the newly grown cartilage to maintain its volume during cultivation and post-procedure.

"The cell-derived scaffold could provide a favorable environment for cartilage cells to maintain their characteristics while synthesizing cartilage in the scaffold structure in vivo," notes study author Dr. Byoung-Hyun Min. "Cell-derived scaffolding may hold great promise for the future. A variety of applications are possible for the engineering of cartilage tissue as the shape and porosity can be altered to suit the type of tissue required."


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
9-May-2007


Page: 1

Related medicine news :

1. Tissue engineering for craniofacial reconstruction
2. Tissue engineering experts discuss orthopaedics applications
3. Public meeting Jan. 4 on research priorities on EHS aspects of engineered nanoscale materials
4. Bioengineered tissue implants regenerate damaged knee cartilage
5. Scientists report success implanting tissue-engineered bladders into humans
6. Arteries bio-engineered from elderly cells
7. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
8. Microscopic scaffolding offers a simple solution to treating skin injuries
9. A pioneering system allows autistic children to communicate with their environment
10. Study finds wake up and breathe strategy allows patients to come off ventilator sooner
11. Remote device allows cardiologist to monitor patients daily at their homes

Post Your Comments:
(Date:11/24/2009)... NCL Security Launches EyeCentral Remote Video ...urring Monthly Revenue for Central Stations and Se... Texas (PRWEB) November 24, 2009 -- NCL Security L...ecurity Industry to Generate Recurring Monthly Rev... ,"Integrated security systems has been and s...
(Date:11/23/2009)...s study by researchers from Virginia Commonwealth ...mpaired peroxisomal oxidation of polyunsaturated f...on of nonalcoholic fatty liver (NAFL) to nonalcoho... significantly higher plasma monounsaturated fatty.... Full findings appear in the December issue of ...
(Date:11/23/2009)... After suffering from women,s hair loss for alm...ack and she,s sharing her progress and the secret ...hrough the release of her video diaries which incl...ing her treatment. , (PRW...sufferer Zsanett Siklosi has released the video di...
(Date:11/23/2009)...etoTargetIndividualsintheRecommendedPriorityGroups...re/--TheDepartmentofHealthannouncedtodaytheywillco...tateHealthCentersinDelaware,Lancaster,andLehighcou...accinewillbeadministeredforfreetoindividualsinther...tothevaccine.Thedepartmentasksthatonlyindividualsi...
(Date:11/23/2009)...th care professionals enjoy a pay raise for a job ...ives for health care performance may actually back...are performance ratings for 25 medical groups acro... launch of a statewide pay-for-performance program...rs, productivity. , Reporting in the December...
Breaking Medicine News(10 mins):Health News:NCL Security Launches EyeCentral Video Platform for the Security Industry to Generate Recurring Monthly Revenue for Central Stations and Security Dealers 2Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3
(Date:11/23/2009)..., LASVEGAS,Nov.23/PRNewswire-FirstCall/--CordBlood...rdbloodstemcellpreservationcompany( http://www.cor...potentialofstemcells,abiologicalinsurancepolicy,to...ythatanupdatedprogressinterviewwithCEOandco-founde...terviewisat: http://blip.tv/file/2875811 . ,, I...
(Date:11/23/2009)..., PRINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pha...rollmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;...notype1and4patientsintheongoingphase2btrialofRG712...orforthetreatmentofchronichepatitisCvirus(HCV)infe...anindependentDataMonitoringCommittee(DMC)ofallavai...
(Date:11/23/2009)..., NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Rapt...aq: RPTP ),todayannouncedresultsfromaPhase2bclinic...tartrate("DRCysteamine")inpatientswithnephropathic...iversityofCalifornia,SanDiego("UCSD")GeneralClinic...macokineticsandpharmacodynamicsofasingledoseofDRCy...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 1BioMarin to Host Second Quarter 2009 Financial Results Conference Call and Webcast on Thursday July 30 at 5 3A00 p m ET 2823 3A00 CET 29 50515 2Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 1Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 2Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 3Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 4Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 5Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 6Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 7Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 8Schering Plough Announces Phase II and III Data for Corifollitropin Alfa 12868 9Antibiotics May Boost Risk for Recurrent Ear Infection 50511 1Antibiotics May Boost Risk for Recurrent Ear Infection 50511 2
Other News:
...research presented today at Digestive Disease Week...nts for gastroesophageal reflux (GERD) symptoms ma...bed by a physician. DDW is the largest internatio...mics in the fields of gastroenterology, hepatology...
...escription medications in specially designed blist...e likelihood that medications will be taken proper...study found that patients taking lisinopril a med... were more likely to have their prescriptions refi...
...ctivity in reducing colon and breast cancer are we... ovarian cancer have been inconclusive. Because ov... more important to identify modifiable lifestyle f...ed online May 16, 2005 in the International Journa...
...s) has gone up substantially, but the number of pu...hers to question the utilization of this procedure...nt who underwent a CTA for suspected pulmonary emb...) in 2002, 2003 and 2004. "The total number of CTA...
health news:OTC treatments for reflux fail to match relief of prescriptions 2health news:Changing medication packages could help patients follow prescriptions, study suggests 2health news:Changing medication packages could help patients follow prescriptions, study suggests 3health news:The link between physical activity and ovarian cancer 2
...n cancer control and detection at The Ohio State U...receiving a second award from The Breast Cancer Re...o the relationship between diet and breast cancer ...te director for population sciences at the OSUCCC ...
...life expectancy after cancer diagnosis have been t...sue of THE LANCET.......There are two main ways of...osis. The conventional method, known as the cohort...ncer patients whose diagnosis occurred many years ...
...e significant economic implications for women in t...niversity of Alberta researcher. Heavy or otherwis...among women in the reproductive-age range. Until n... from work.......Dr. David Cumming, a professor of...
...a surgical procedure in Parkinson's disease (PD) p...or those with moderate to advanced stages of the d...al pilot study. Researchers in Cuba, in collabora...rom Emory University and other centers in the U.S....
health news:Lauder supports James nutrition and breast cancer study 2health news:Lauder supports James nutrition and breast cancer study 3health news:Cancer survival rates higher than previously assumed 2health news:New Parkinson's surgical procedure shows lasting benefits, according to Emory researchers 2health news:New Parkinson's surgical procedure shows lasting benefits, according to Emory researchers 3health news:New Parkinson's surgical procedure shows lasting benefits, according to Emory researchers 4